Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 7, Issue 17
September 12 2023
Issue Cover

Table of Contents

INSIDE BLOOD ADVANCES

Natalizumab for GVHD: too little or too late?
Clinical Trials & Observations
Kevin Quann,Faruk Sacirbegovic,Warren D. Shlomchik
View Articletitled, Natalizumab for GVHD: too little or too late?

REVIEW ARTICLE

Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD
Nataliya P. Buxbaum,Gerard Socié,Geoffrey R. Hill,Kelli P. A. MacDonald,Victor Tkachev,Takanori Teshima,Stephanie J. Lee,Jerome Ritz,Stefanie Sarantopoulos,Leo Luznik,Defu Zeng,Sophie Paczesny,Paul J. Martin,Steven Z. Pavletic,Kirk R. Schultz,Bruce R. Blazar
View Articletitled, Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD

CLINICAL TRIALS AND OBSERVATIONS

Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia
Clinical Trials & Observations
Chaitra Ujjani,Ted A. Gooley,Stephen E. Spurgeon,Deborah M. Stephens,Catherine Lai,Catherine M. Broome,Susan O’Brien,Haiying Zhu,Kerry J. Laing,Allison M. Winter,Georgios Pongas,Alexander L Greninger,David M. Koelle,Tanya Siddiqi,Matthew S. Davids,Kerry A. Rogers,Alexey V. Danilov,Amy Sperling,Brian Tu,Tyler Sorensen,Kelsey Launchbury,Carlissa J. Burrow,Genesis Quezada,Joshua A. Hill,Mazyar Shadman,Philip A. Thompson
View Articletitled, Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia
Supplemental data
Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study
Clinical Trials & Observations
Won-Seog Kim,Noriko Fukuhara,Dok-Hyun Yoon,Kazuhito Yamamoto,Toshiki Uchida,Eiju Negoro,Koji Izutsu,Yasuhito Terui,Hideaki Nakajima,Kiyoshi Ando,Youko Suehiro,Hye Jin Kang,Po-Shen Ko,Fumiko Nagahama,Yusuke Sonehara,Hirokazu Nagai,Hwei-Fang Tien,Yok-Lam Kwong,Kensei Tobinai
View Articletitled, Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study
Anti-CD19 CAR T-cell consolidation therapy combined with CD19+ feeding T cells and TKI for Ph+ acute lymphoblastic leukemia
Clinical Trials & Observations
Li-Yun Chen,Wen-Jie Gong,Ming-Hao Li,Hai-Xia Zhou,Ming-Zhu Xu,Chong-Sheng Qian,Li-Qing Kang,Nan Xu,Zhou Yu,Man Qiao,Tong-Tong Zhang,Ling Zhang,Zheng-Long Tian,Ai-Ning Sun,Lei Yu,De-Pei Wu,Sheng-Li Xue
View Articletitled, Anti-CD19 CAR T-cell consolidation therapy combined with CD19<sup>+</sup> feeding T cells and TKI for Ph<sup>+</sup> acute lymphoblastic leukemia
Supplemental data
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
Clinical Trials & Observations
Nancy L. Bartlett,Sarit Assouline,Pratyush Giri,Stephen J. Schuster,Chan Y. Cheah,Matthew Matasar,Gareth P. Gregory,Dok Hyun Yoon,Mazyar Shadman,Keith Fay,Sung-Soo Yoon,Carlos Panizo,Ian Flinn,Anna Johnston,Francesc Bosch,Laurie H. Sehn,Michael C. Wei,Shen Yin,Iris To,Chi-Chung Li,Huang Huang,Antonia Kwan,Elicia Penuel,Lihua E. Budde
View Articletitled, Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
Supplemental data
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
Clinical Trials & Observations
Anna B. Halpern,Eduardo Rodríguez-Arbolí,Megan Othus,Kelsey-Leigh A. Garcia,Mary-Elizabeth M. Percival,Ryan D. Cassaday,Vivian G. Oehler,Pamela S. Becker,Jacob S. Appelbaum,Janis L. Abkowitz,Johnnie J. Orozco,Siobán B. Keel,Paul C. Hendrie,Bart L. Scott,M. Cristina Ghiuzeli,Elihu H. Estey,Roland B. Walter
View Articletitled, Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
Clinical Trials & Observations
Pierre Fenaux,Marco Gobbi,Patricia L. Kropf,Jean-Pierre J. Issa,Gail J. Roboz,Jiri Mayer,Jürgen Krauter,Tadeusz Robak,Hagop Kantarjian,Jan Novak,Wieslaw. W. Jedrzejczak,Xavier Thomas,Mario Ojeda-Uribe,Yasushi Miyazaki,Yoo Hong Min,Su-Peng Yeh,Joseph Brandwein,Liana Gercheva-Kyuchukova,Judit Demeter,Elizabeth Griffiths,Karen Yee,Konstanze Döhner,Yong Hao,Harold Keer,Mohammad Azab,Hartmut Döhner
View Articletitled, Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
Supplemental data
Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study
Clinical Trials & Observations
Narendranath Epperla,Qiuhong Zhao,Reem Karmali,Pallawi Torka,Lauren Shea,Timothy S. Oh,Andrea Anampa-Guzmán,Heather Reves,Montreh Tavakkoli,Irl Brian Greenwell,Emily Hansinger,Elvira Umyarova,Kaitlin Annunzio,Yazeed Sawalha,Beth Christian,Colin Thomas,Stefan K. Barta,Praveen Ramakrishnan Geethakumari,Nancy L. Bartlett,Natalie S. Grover,Adam J. Olszewski
View Articletitled, Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study
Supplemental data
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
Clinical Trials & Observations
Monzr M. Al Malki,Kaitlyn London,Janna Baez,Yu Akahoshi,William J. Hogan,Aaron Etra,Hannah Choe,Elizabeth Hexner,Amelia Langston,Sunil Abhyankar,Doris M. Ponce,Zachariah DeFilipp,Carrie L. Kitko,Kehinde Adekola,Ran Reshef,Francis Ayuk,Alexandra Capellini,Chantiya Chanswangphuwana,Matthias Eder,Gilbert Eng,Isha Gandhi,Stephan Grupp,Sigrun Gleich,Ernst Holler,Nora Rebeka Javorniczky,Stelios Kasikis,Steven Kowalyk,George Morales,Umut Özbek,Wolf Rösler,Nikolaos Spyrou,Gregory Yanik,Rachel Young,Yi-Bin Chen,Ryotaro Nakamura,James L. M. Ferrara,John E. Levine
View Articletitled, Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
Supplemental data
Natalizumab for GVHD: too little or too late?
Clinical Trials & Observations
Kevin Quann,Faruk Sacirbegovic,Warren D. Shlomchik
View Articletitled, Natalizumab for GVHD: too little or too late?

HEALTH SERVICES AND OUTCOMES

Prevalence of frailty and its association with clinical outcomes in myeloproliferative neoplasms: a population-based study
Clinical Trials & Observations
Aniket Bankar,Wing C. Chan,Ning Liu,Matthew Cheung,Shabbir Alibhai,Vikas Gupta
View Articletitled, Prevalence of frailty and its association with clinical outcomes in myeloproliferative neoplasms: a population-based study
Supplemental data

HEMATOPOIESIS AND STEM CELLS

An NFIX-mediated regulatory network governs the balance of hematopoietic stem and progenitor cells during hematopoiesis
Megan Walker,Yichao Li,Antonio Morales-Hernandez,Qian Qi,Chaithanyarani Parupalli,Scott Brown,Claiborne Christian,Wilson K. Clements,Yong Cheng,Shannon McKinney-Freeman
View Articletitled, An NFIX-mediated regulatory network governs the balance of hematopoietic stem and progenitor cells during hematopoiesis
Supplemental data

IMMUNOBIOLOGY AND IMMUNOTHERAPY

Host metabolome predicts the severity and onset of acute toxicities induced by CAR T-cell therapy
Akansha Jalota,Courtney E. Hershberger,Manishkumar S. Patel,Agrima Mian,Aiman Faruqi,Gholamreza Khademi,Daniel M. Rotroff,Brian T. Hill,Neetu Gupta
View Articletitled, Host metabolome predicts the severity and onset of acute toxicities induced by CAR T-cell therapy
Supplemental data
Activated protein C modulates T-cell metabolism and epigenetic FOXP3 induction via α-ketoglutarate
Dheerendra Gupta,Ahmed Elwakiel,Satish Ranjan,Manish Kumar Pandey,Shruthi Krishnan,Saira Ambreen,Reinhard Henschler,Rajiv Rana,Maria Keller,Uta Ceglarek,Khurrum Shahzad,Shrey Kohli,Berend Isermann
View Articletitled, Activated protein C modulates T-cell metabolism and epigenetic FOXP3 induction via α-ketoglutarate
Supplemental data
Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia
Sanam Shahid,Nicholas Ceglia,Jean-Benoît Le Luduec,Andrew McPherson,Barbara Spitzer,Theodota Kontopoulos,Viktoria Bojilova,M. Kazim Panjwani,Mikhail Roshal,Sohrab P. Shah,Omar Abdel-Wahab,Benjamin Greenbaum,Katharine C. Hsu
View Articletitled, Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia
Supplemental data

LYMPHOID NEOPLASIA

Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
Reid W. Merryman,Robert A. Redd,Eleanor Taranto,Gulrayz Ahmed,Erin Jeter,Kristin M. McHugh,Jennifer R. Brown,Jennifer L. Crombie,Matthew S. Davids,David C. Fisher,Arnold S. Freedman,Eric Jacobsen,Caron A. Jacobson,Austin I. Kim,Ann S. LaCasce,Samuel Y. Ng,Oreofe O. Odejide,Erin M. Parry,Heather Jacene,Hyesun Park,Parastoo B. Dahi,Yago Nieto,Robin M. Joyce,Yi-Bin Chen,Margaret A. Shipp,Alex F. Herrera,Philippe Armand
View Articletitled, Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
Supplemental data
Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome
Shakthi T. Bhaskar,Vivek G. Patel,David L. Porter,Stephen J. Schuster,Loretta J. Nastoupil,Miguel-Angel Perales,Ana Alarcon Tomas,Michael R. Bishop,Joseph P. McGuirk,Richard T. Maziarz,Andy I. Chen,Veronika Bachanova,Joseph E. Maakaron,Peter A. Riedell,Olalekan O. Oluwole
View Articletitled, Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome
Retrospective characterization of nodal marginal zone lymphoma
Robert Stuver,Esther Drill,David Qualls,Michelle Okwali,Connie Lee Batlevi,Philip C. Caron,Ahmet Dogan,Zachary D. Epstein-Peterson,Lorenzo Falchi,Paul A. Hamlin,Steven M. Horwitz,Brandon S. Imber,Andrew M. Intlekofer,William T. Johnson,Niloufer Khan,Anita Kumar,Oscar B. Lahoud,Jennifer Kimberly Lue,Matthew J. Matasar,Alison J. Moskowitz,Ariela Noy,Colette N. Owens,M. Lia Palomba,Heiko Schöder,Santosha A. Vardhana,Joachim Yahalom,Andrew D. Zelenetz,Gilles Salles,David J. Straus
View Articletitled, Retrospective characterization of nodal marginal zone lymphoma
Supplemental data
YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia
Huan Li,Danlan Zhang,Qiuxia Fu,Shang Wang,Zhongyuan Wang,Xin Zhang,Xin Chen,Xiaoyu Zhu,Na An,Yun Chen,Liang Zhou,Desheng Lu,Na Zhao
View Articletitled, YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia
Supplemental data
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network
Greg Hapgood,Monica Civallero,Yana Stepanishyna,Julie Vose,Monica Elena Cabrera,Ranjana H. Advani,Stefano A. Pileri,Martina Manni,Steven M. Horwitz,Francine M. Foss,Felicitas Hitz,John Radford,Ivan Dlouhy,Carlos Chiattone,Won Seog Kim,Tetiana Skrypets,Arnon Nagler,Judith Trotman,Stefano Luminari,Massimo Federico,on behalf of the International T-Cell Project
View Articletitled, The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network
Supplemental data
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma
Clinical Trials & Observations
W. Richard Burack,Hongli Li,Diana Adlowitz,Janice M. Spence,Lisa M. Rimsza,Mazyar Shadman,Catherine M. Spier,Mark S. Kaminski,John P. Leonard,Michael L. Leblanc,Sonali M. Smith,Jonathan W. Friedberg
View Articletitled, Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma
Supplemental data
BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through PAX5
Derek B. Oien,Samanta Sharma,Maureen M. Hattersley,Michelle DuPont,Steven W. Criscione,Laura Prickett,Anne U. Goeppert,Lisa Drew,Yi Yao,Jingwen Zhang,Ho Man Chan
View Articletitled, BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through PAX5
Supplemental data
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
William T. Johnson,Nivetha Ganesan,Zachary D. Epstein-Peterson,Alison J. Moskowitz,Robert N. Stuver,Catherine R. Maccaro,Natasha Galasso,Tiffany Chang,Niloufer Khan,Umut Aypar,Natasha E. Lewis,Andrew D. Zelenetz,M. Lia Palomba,Matthew J. Matasar,Ariela Noy,Audrey M. Hamilton,Paul Hamlin,Philip C. Caron,David J. Straus,Andrew M. Intlekofer,Connie Lee Batlevi,Anita Kumar,Colette N. Owens,Craig S. Sauter,Lorenzo Falchi,Jennifer K. Lue,Santosha A. Vardhana,Gilles Salles,Ahmet Dogan,Nikolaus D. Schultz,Maria E. Arcila,Steven M. Horwitz
View Articletitled, <em>TP53</em> mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
Supplemental data

MYELOID NEOPLASIA

Repression of TRIM13 by chromatin assembly factor CHAF1B is critical for AML development
Sarai T. Dean,Chiharu Ishikawa,Xiaoqin Zhu,Sean Walulik,Timothy Nixon,Jessica K. Jordan,Samantha Henderson,Michael Wyder,Nathan Salomonis,Mark Wunderlich,Kenneth D. Greis,Daniel T. Starczynowski,Andrew G. Volk
View Articletitled, Repression of TRIM13 by chromatin assembly factor CHAF1B is critical for AML development
Supplemental data
Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
Clinical Trials & Observations
Joseph G. W. McCarter,David Nemirovsky,Christopher A. Famulare,Noushin Farnoud,Abhinita S. Mohanty,Zoe S. Stone-Molloy,Jordan Chervin,Brian J. Ball,Zachary D. Epstein-Peterson,Maria E. Arcila,Aaron J. Stonestrom,Andrew Dunbar,Sheng F. Cai,Jacob L. Glass,Mark B. Geyer,Raajit K. Rampal,Ellin Berman,Omar I. Abdel-Wahab,Eytan M. Stein,Martin S. Tallman,Ross L. Levine,Aaron D. Goldberg,Elli Papaemmanuil,Yanming Zhang,Mikhail Roshal,Andriy Derkach,Wenbin Xiao
View Articletitled, Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
Supplemental data
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting
Enrico Attardi,Arianna Savi,Beatrice Borsellino,Alfonso Piciocchi,Marta Cipriani,Tiziana Ottone,Emiliano Fabiani,Mariadomenica Divona,Serena Travaglini,Maria Rosaria Pascale,Hussein Awada,Arda Durmaz,Valeria Visconte,Matteo Giovanni Della Porta,Adriano Venditti,Jaroslaw P. Maciejewski,Carmelo Gurnari,Maria Teresa Voso
View Articletitled, Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting
Supplemental data

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

Secondary bile acids function through the vitamin D receptor in myeloid progenitors to promote myelopoiesis
Brandon Thompson,Shan Lu,Julio Revilla,Md Jashim Uddin,David N. Oakland,Savannah Brovero,Sunduz Keles,Emery H. Bresnick,William A. Petri, Jr.,Stacey L. Burgess
View Articletitled, Secondary bile acids function through the vitamin D receptor in myeloid progenitors to promote myelopoiesis
Supplemental data

PLATELETS AND THROMBOPOIESIS

Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITE
Raymond Siu Ming Wong,İrfan Yavaşoğlu,Mohamed A. Yassin,Pınar Tarkun,Sung-Soo Yoon,Xie Wei,Ashraf Elghandour,Pantep Angchaisuksiri,Mehmet Ozcan,Renchi Yang,Mervat Mattar,Masiur Rahman,Sara Ingles,Michael Goldbrunner,Jennifer A. Frueh,Jun Ho Jang
View Articletitled, Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITE
Supplemental data
Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma/Kasabach-Merritt phenomenon
Alexey A. Martyanov,Ivan P. Tesakov,Lili A. Khachatryan,Olga I. An,Anna E. Boldova,Anastasia A. Ignatova,Ekaterina M. Koltsova,Julia-Jessica D. Korobkin,Nadezhda A. Podoplelova,Galina S. Svidelskaya,Eugenia Yushkova,Galina A. Novichkova,Johannes A. Eble,Mikhail A. Panteleev,Dmitrii V. Kalinin,Anastasia N. Sveshnikova
View Articletitled, Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma/Kasabach-Merritt phenomenon
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Splenectomy improves erythrocyte functionality in spherocytosis based on septin abundance, but not maturation defects
Anne-Sophie Cloos,Hélène Pollet,Amaury Stommen,Mauriane Maja,Maxime Lingurski,Bénédicte Brichard,Catherine Lambert,Patrick Henriet,Christophe Pierreux,Sébastien Pyr dit Ruys,Patrick Van Der Smissen,Miikka Vikkula,Laurent Gatto,Manon Martin,Pascal Brouillard,Didier Vertommen,Donatienne Tyteca
View Articletitled, Splenectomy improves erythrocyte functionality in spherocytosis based on septin abundance, but not maturation defects
Supplemental data
Genome-wide meta-analysis identifies new candidate genes for sickle cell disease nephropathy
Melanie E. Garrett,Karen L. Soldano,Kyle N. Erwin,Yingze Zhang,Victor R. Gordeuk,Mark T. Gladwin,Marilyn J. Telen,Allison E. Ashley-Koch
View Articletitled, Genome-wide meta-analysis identifies new candidate genes for sickle cell disease nephropathy
Supplemental data
The transcriptomic landscape of normal and ineffective erythropoiesis at single-cell resolution
Raymond T. Doty,Christopher G. Lausted,Adam D. Munday,Zhantao Yang,Xiaowei Yan,Changting Meng,Qiang Tian,Janis L. Abkowitz
View Articletitled, The transcriptomic landscape of normal and ineffective erythropoiesis at single-cell resolution
Supplemental data
Bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in a mouse model of iron deficiency anemia
Xiuqi Li,Larisa Lozovatsky,Steven M. Tommasini,Jackie Fretz,Karin E. Finberg
View Articletitled, Bone marrow sinusoidal endothelial cells are a site of <em>Fgf23</em> upregulation in a mouse model of iron deficiency anemia
Supplemental data

THROMBOSIS AND HEMOSTASIS

The prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis
Clinical Trials & Observations
Charles Hsu,Rushad Patell,Jeffrey I. Zwicker
View Articletitled, The prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis
Supplemental data
Anti-FVIII antibodies in Black and White hemophilia A subjects: do F8 haplotypes play a role?
Kathleen P. Pratt,Devi Gunasekera,Pooja Vir,Siyuan Tan,Glenn F. Pierce,Cara Olsen,Saulius Butenas,Kenneth G. Mann
View Articletitled, Anti-FVIII antibodies in Black and White hemophilia A subjects: do <em>F8</em> haplotypes play a role?
Supplemental data
A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura
Clinical Trials & Observations
Tanja Falter,Heidi Rossmann,Laure de Waele,Charlotte Dekimpe,Charis von Auer,Nadine Müller-Calleja,Friederike Häuser,Adriana Degreif,Dana Marandiuc,Xavier Messmer,Martin Sprinzl,Karl J. Lackner,Kerstin Jurk,Karen Vanhoorelbeke,Bernhard Lämmle
View Articletitled, A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura
Supplemental data

TRANSFUSION MEDICINE

Proinflammatory state promotes red blood cell alloimmunization in pediatric patients with sickle cell disease
Yan Zheng,Jeffrey M. Gossett,Pei-Lin Chen,Martha Barton,Missy Ryan,Jing Yu,Guolian Kang,Jane S. Hankins,Stella T. Chou
View Articletitled, Proinflammatory state promotes red blood cell alloimmunization in pediatric patients with sickle cell disease
Supplemental data

TRANSPLANTATION

Novel risk assessment for the intensity of conditioning regimen in older patients
Yu Akahoshi,Yuma Tada,Emiko Sakaida,Machiko Kusuda,Noriko Doki,Naoyuki Uchida,Takahiro Fukuda,Masatsugu Tanaka,Masashi Sawa,Yuta Katayama,Ken-ichi Matsuoka,Yukiyasu Ozawa,Makoto Onizuka,Junya Kanda,Yoshinobu Kanda,Yoshiko Atsuta,Hideki Nakasone
View Articletitled, Novel risk assessment for the intensity of conditioning regimen in older patients
Supplemental data
Assessment of HLA-DPB1 genetic variation using an HLA-DP tool and its implications in clinical transplantation
Ray Sajulga,Yung-Tsi Bolon,Martin J. Maiers,Effie W. Petersdorf
View Articletitled, Assessment of <em>HLA-DPB1</em> genetic variation using an HLA-DP tool and its implications in clinical transplantation
Supplemental data
Intestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis
YunZu Michele Wang,Sheyar Abdullah,Nathan Luebbering,Lucille Langenberg,Alexandra Duell,Kelly Lake,Adam Lane,Brian Hils,Ormarie Vazquez Silva,Monica Trapp,Kodandaramireddy Nalapareddy,Jane Koo,Lee A. Denson,Sonata Jodele,David B. Haslam,William A. Faubion,Stella M. Davies,Pooja Khandelwal
View Articletitled, Intestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis
Supplemental data

RESEARCH LETTERS

Flow cytometry as a fast, cost-effective tool to assess IGHV mutational status in CLL
Guillaume Couillez,Pierre Morel,Valentin Clichet,Ludivine Fourdrain,Caroline Delette,Véronique Harrivel,Brigitte Gubler,Camille Rottier,Sophie Derreumaux,Emilie Margat,Loic Garcon,Jean-Pierre Marolleau,Thomas Boyer
View Articletitled, Flow cytometry as a fast, cost-effective tool to assess <em>IGHV</em> mutational status in CLL
Supplemental data
Real-world prognostic testing and treatment patterns in CLL/SLL: results from 1462 patients in the informCLL registry
Clinical Trials & Observations
Anthony R. Mato,Nilanjan Ghosh,Jeff P. Sharman,Danielle Brander,Meghan Gutierrez,Qing Huang,Linda H. Wu,Alex Young,Sandhya Upasani,Maoko Naganuma,Jacqueline C. Barrientos
View Articletitled, Real-world prognostic testing and treatment patterns in CLL/SLL: results from 1462 patients in the informCLL registry
Supplemental data
Detrimental effects of sickle cell disease and hydroxycarbamide on ovarian reserve but uncertain impact on fertility
Clinical Trials & Observations
Laure Joseph,Sandra Manceau,Didier Borderie,Catherine Patrat,Jean Benoit Arlet,Benoit Meunier,Marina Cavazzana,Pietro Santulli,Virginie Barraud-Lange
View Articletitled, Detrimental effects of sickle cell disease and hydroxycarbamide on ovarian reserve but uncertain impact on fertility
Supplemental data
No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: a population-based study
Emma E. Geerdes,Müjde Durmaz,Pieternella J. Lugtenburg,Martine E. D. Chamuleau,Otto Visser,Djamila E. Issa,Rolf E. Brouwer,Eduardus F. M. Posthuma,Josée M. Zijlstra,Marie José Kersten,Avinash G. Dinmohamed
View Articletitled, No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: a population-based study
Supplemental data
Treatment delays in children and young adults with lymphoma: a report from an East Africa lymphoma cohort study
Global Advances
William Frank Mawalla,Liz Morrell,Lulu Chirande,Caroline Achola,Hadija Mwamtemi,Godlove Sandi,Salama Mahawi,Atukuzwe Kahakwa,Paul Ntemi,Nabalende Hadija,Elifuraha Mkwizu,Clara Chamba,Dimitris Vavoulis,Anna Schuh
View Articletitled, Treatment delays in children and young adults with lymphoma: a report from an East Africa lymphoma cohort study
Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia B
Clinical Trials & Observations
Manfred Schmidt,Graham R. Foster,Michiel Coppens,Hauke Thomsen,Ricardo Dolmetsch,Liesbeth Heijink,Paul E. Monahan,Steven W. Pipe
View Articletitled, Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia B
Supplemental data
Patient-reported outcomes in children with sickle cell disease at presentation for an acute pain episode
Clinical Trials & Observations
Nitya Bakshi,Zihao Liu,Scott Gillespie,Rohali Keesari,Deborah Leake,Kirshma Khemani,Polly Kumari,Chris A. Rees,Carlton Dampier,Claudia R. Morris
View Articletitled, Patient-reported outcomes in children with sickle cell disease at presentation for an acute pain episode
Supplemental data
Safe and efficient lentiviral vector integration with HSC-targeted gene therapy
Stefan Radtke,Dnyanada Pande,Mark Enstrom,Hans-Peter Kiem
View Articletitled, Safe and efficient lentiviral vector integration with HSC-targeted gene therapy
Supplemental data
The utility of biomarkers in acute GVHD prognostication
Clinical Trials & Observations
Nikolaos Spyrou,Yu Akahoshi,Francis Ayuk,Ernst Holler,Hannah Choe,Aaron Etra,William J. Hogan,Wolf Rösler,Elizabeth Hexner,Zachariah DeFilipp,Ran Reshef,Chantiya Chanswangphuwana,Muna Qayed,Sabrina Kraus,Matthias Eder,Nora Rebeka Javorniczky,Stephan A. Grupp,Carrie L. Kitko,Pietro Merli,Paibel Aguayo-Hiraldo,Matthias Wölfl,Janna Baez,Rahnuma Beheshti,Gilbert Eng,Sigrun Gleich,Nikolaos Katsivelos,Alina Khan,Steven Kowalyk,George Morales,Rachel Young,Ryotaro Nakamura,Yi-Bin Chen,John E. Levine,James L. M. Ferrara
View Articletitled, The utility of biomarkers in acute GVHD prognostication
Supplemental data

ERRATUM

Crouch S, Painter D, Barrans SL, et al. Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network. Blood Adv. 2022;6(21):5716-5731.
View Articletitled, Crouch S, Painter D, Barrans SL, et al. Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network. <em>Blood Adv</em>. 2022;6(21):5716-5731.
Supplemental data
All Issues

Advertisement intended for health care professionals

Histiocytosis of the orbit and its association with KRAS mutations
NUP98 is rearranged in 5.0% of adult East Asian patients with AML
Addressing financial hardship in malignant hematology and hematopoietic cell transplant: a team approach
CT strain metrics allow for earlier diagnosis of bronchiolitis obliterans syndrome after hematopoietic cell transplant
Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD+ acute myeloid leukemia

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals